LIP
PBYI icon

Lighthouse Investment Partners’s Puma Biotechnology PBYI Stock Holding History

Lighthouse Investment Partners’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,276
Closed -$34.8K – 363
2023
Q1 		$34.8K Buy
+11,276
New +$42.5K ﹤0.01% 257

Other funds holding PBYI

CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $783M AUM 81.58% 1-Year Est. Return

Lighthouse Investment Partners's PBYI Position: Q2 2023 in Review

Lighthouse Investment Partners sold out of Puma Biotechnology (PBYI) in Q2 2023, closing a stake of 11,276 shares — an estimated $34.8K sold.

Lighthouse Investment Partners first reported a position in PBYI in Q1 2023 and held it in 1 quarter. The position peaked at $34.8K in Q1 2023. 68 funds tracked by Wall St. Rank hold PBYI as of Q2 2023.

  • Lighthouse Investment Partners reported no remaining Puma Biotechnology position as of Q2 2023 after selling out during the quarter.
  • Lighthouse Investment Partners sold 11,276 Puma Biotechnology shares in Q2 2023, an estimated $34.8K.
  • Lighthouse Investment Partners first reported a position in Puma Biotechnology in Q1 2023 and held it in 1 quarter.
  • Lighthouse Investment Partners's Puma Biotechnology position peaked at $34.8K in Q1 2023.
  • 68 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2023.

Based on Lighthouse Investment Partners's 13F filing for Q2 2023, filed 14 Aug 2023.